Extended Data Fig. 2: Tumor enriched myeloid cells exhibits the highest immune-inhibitory signatures in big data.

a–c. UMAP projection of 455,959 immune cells in 131 CRC patients from syn26844071, GSE188711 and GSE178341, colored by cell type (a), tissue (b) and TNM stage (c). d. Immune-inhibitory scores of each cell type in tumor tissues. e. The significantly enriched signatures of TAM specific genes. Color depth represents -Log10 (p value). f-k. The expression of immune-inhibitory genes on macrophages (f) and neutrophils (g) from all the 131 CRC patients, as well as macrophages from stage I (h), stage II (i), stage III (j), and stage IV (k), between tumor and normal tissues (Wilcoxon test, two-sided).